Invention Grant
US08188101B2 Dihydropyridopyrimidines for the treatment of AB-related pathologies
失效
二氢吡啶并嘧啶用于治疗AB相关病变
- Patent Title: Dihydropyridopyrimidines for the treatment of AB-related pathologies
- Patent Title (中): 二氢吡啶并嘧啶用于治疗AB相关病变
-
Application No.: US12613935Application Date: 2009-11-06
-
Publication No.: US08188101B2Publication Date: 2012-05-29
- Inventor: Rickard Forsblom , Kim Paulsen , Didier Rotticci , Ellen Santangelo , Magnus Waldman
- Applicant: Rickard Forsblom , Kim Paulsen , Didier Rotticci , Ellen Santangelo , Magnus Waldman
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agent Kenneth F. Mitchell
- Main IPC: A61K31/519
- IPC: A61K31/519
Abstract:
Dihydropyridopyrimidine compounds of formula (Ia) and therapeutically acceptable salts thereof, wherein R1, R2 and Z are as defined in the specification; processes for making them and methods for using them in the treatment of Aβ-related pathologies.
Public/Granted literature
- US20100130495A1 COMPOUNDS 563 Public/Granted day:2010-05-27
Information query
IPC分类:
